Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The goal of this trial is to test the efficacy and safety of cardenilimab combined with
chemotherapy in the conversion therapy of locally advanced unresectable esophageal squamous
cell carcinoma.
type of study: clinical trial